Literature DB >> 8513441

c-Ha-Ras mutants with point mutations in Gln-Val-Val region have reduced inhibitory activity toward cathepsin B.

T Hiwasa1, J Fujita-Yoshigaki, M Shirouzu, H Koide, T Sawada, S Sakiyama, S Yokoyama.   

Abstract

Protease-inhibitory activity of recombinant Ha-ras gene products (Ras) toward papain and cathepsins B and L was investigated. v-Ha-Ras showed more potent inhibitory activity toward cathepsin B as compared with c-Ha-Ras. We have also investigated protease-inhibitory activity of c-Ha-Ras mutants with point mutations in amino acids between positions 23 and 50. Inhibitory activity of Ras toward papain and cathepsin L was not largely altered among mutants. However, the inhibitory activity toward cathepsin B was significantly impaired by a mutation at position 43, 44, 45 or 48. These results suggest that 43Gln-Val-Val sequence plays an important role at least to inhibit cathepsin B.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513441     DOI: 10.1016/0304-3835(93)90169-a

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  2 in total

1.  Lactomycins A-C, Dephosphorylated Phoslactomycin Derivatives that Inhibit Cathepsin B, from the Marine-derived Streptomyces sp. ACT232.

Authors:  Yi Sun; Rogie Royce Carandang; Yuta Harada; Shigeru Okada; Kazutoshi Yoshitake; Shuichi Asakawa; Yuichi Nogi; Shigeki Matsunaga; Kentaro Takada
Journal:  Mar Drugs       Date:  2018-02-21       Impact factor: 5.118

2.  Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease.

Authors:  Hiroyuki Konno; Masaki Wakabayashi; Daiki Takanuma; Yota Saito; Kenichi Akaji
Journal:  Bioorg Med Chem       Date:  2016-01-29       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.